Quebec City, July 29, 2022 - Pharma in silica acquires ownership of three three pending patent families that form the basis of its technology OpKemo technology.

Pharma in silica's co-founder, SiliCycle, had previously granted Pharma in silica an exclusive license for all pharmaceutical uses.